Articles related to PATIENT CARE

Updated AAN and AHS guidance outlines when to initiate preventive migraine therapy, how to select treatments based on efficacy and tolerability, and how to tailor management for special populations and comorbidities.

Growing numbers of cancer survivors are prompting renewed discussion about how survivorship services should be delivered, with oncology and palliative care leaders emphasizing symptom management, quality of life, clinician training, and long-term support needs.

A 16-year-old girl presented with acute aphasia and right-sided weakness consistent with a large-vessel stroke syndrome. Neuroimaging confirmed left middle cerebral artery occlusion, but the underlying etiology was not immediately apparent.

U.S. News expanded its 2026-2027 hospital rankings with new regional specialty evaluations in cancer and cardiovascular care while increasing recognition for regional hospitals. Rankings continued to emphasize risk-adjusted mortality, preventable complications, patient experience, and objective outcomes measures.

The FDA approved Furoscix ReadyFlow, a subcutaneous furosemide autoinjector for edema associated with heart failure or chronic kidney disease. Clinical data demonstrated pharmacokinetic exposure and diuretic effects comparable to intravenous furosemide.

ASCO released updated recommendations for recurrent ovarian cancer that reinforce platinum-based doublet therapy as the preferred approach for platinum-sensitive disease and provide guidance for platinum-resistant disease, maintenance strategies, and monitoring. Recommendations were derived from a systematic review of studies published through 2025.